These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34340244)

  • 41. Cardiovascular Complications in Coronavirus Disease 2019-Pathogenesis and Management.
    Restrepo MI; Marin-Corral J; Rodriguez JJ; Restrepo V; Cavallazzi R
    Semin Respir Crit Care Med; 2023 Feb; 44(1):21-34. PubMed ID: 36646083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Burden of Cardiovascular Diseases Due to COVID-19 Pandemic.
    Hussain MS; Sharma G
    Thorac Cardiovasc Surg; 2024 Jan; 72(1):40-50. PubMed ID: 35987194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular impact of COVID-19 with a focus on children: A systematic review.
    Rodriguez-Gonzalez M; Castellano-Martinez A; Cascales-Poyatos HM; Perez-Reviriego AA
    World J Clin Cases; 2020 Nov; 8(21):5250-5283. PubMed ID: 33269260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac injuries in coronavirus disease 2019 (COVID-19).
    Chen C; Li H; Hang W; Wang DW
    J Mol Cell Cardiol; 2020 Aug; 145():25-29. PubMed ID: 32526224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.
    Tanwar V; Adelstein JM; Wold LE
    Cardiovasc Res; 2021 Jan; 117(1):85-95. PubMed ID: 33084879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial injury and COVID-19: Possible mechanisms.
    Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
    Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications.
    Ma L; Song K; Huang Y
    J Cardiothorac Vasc Anesth; 2021 Jun; 35(6):1860-1865. PubMed ID: 32451271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spectrum of Cardiovascular Diseases in Children During High Peak Coronavirus Disease 2019 Period Infection in Northern Italy: Is There a Link?
    Fabi M; Filice E; Andreozzi L; Conti F; Gabrielli L; Balducci A; Vergine G; Cicero C; Iughetti L; Guerzoni ME; Corinaldesi E; Lazzarotto T; Pession A; Lanari M
    J Pediatric Infect Dis Soc; 2021 Aug; 10(6):714-721. PubMed ID: 33283237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review.
    Saed Aldien A; Ganesan GS; Wahbeh F; Al-Nassr N; Altarawneh H; Al Theyab L; Saed Aldien S; Tomerak S; Naveed H; Elshazly MB; Zakaria D
    Cardiovasc Revasc Med; 2022 Feb; 35():169-178. PubMed ID: 33952432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.
    Zhang Y; Wang L; Wei S
    Braz J Cardiovasc Surg; 2021 Oct; 36(5):685-690. PubMed ID: 33355798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
    Shi X; Chen M; Zhang Y
    Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
    Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
    High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
    Wu L; O'Kane AM; Peng H; Bi Y; Motriuk-Smith D; Ren J
    Biochem Pharmacol; 2020 Aug; 178():114114. PubMed ID: 32579957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Covid-19 and the cardiovascular system: a comprehensive review.
    Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
    J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 and the cardiovascular system: an update.
    Salabei JK; Asnake ZT; Ismail ZH; Charles K; Stanger GT; Abdullahi AH; Abraham AT; Okonoboh P
    Am J Med Sci; 2022 Aug; 364(2):139-147. PubMed ID: 35151635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
    Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
    Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular complications and its impact on outcomes in COVID-19.
    Kunal S; Sharma SM; Sharma SK; Gautam D; Bhatia H; Mahla H; Sharma S; Bhandari S
    Indian Heart J; 2020; 72(6):593-598. PubMed ID: 33357651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Research advances in cardiovascular system damage caused by SARS-CoV-2 in children].
    Xiao HH; Wang X; Xu Y; Wang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Apr; 22(4):299-304. PubMed ID: 32312365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular and Cerebrovascular Complications With COVID-19.
    Greenberg A; Pemmasani G; Yandrapalli S; Frishman WH
    Cardiol Rev; 2021 May-Jun 01; 29(3):143-149. PubMed ID: 33758123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 and cardiovascular diseases.
    Liu F; Liu F; Wang L
    J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.